---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-326102"
form_type: "8-K"
ticker: "IMA"
cik: "0001835579"
company_name: "ImageneBio, Inc."
filed_at: "2021-11-10T23:59:59+00:00"
generated_at: "2026-06-28T10:14:27.698059+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Ikena Oncology updates corporate presentation; no specific new data in filing body

## Summary
- Company updated its corporate presentation on Nov 10, 2021, furnished as Exhibit 99.1.
- Presentation will be posted on the investor relations section of Ikena's website.
- No financial or pipeline specifics are disclosed in the 8-K text itself.

## SEC filing metadata
- accession: 0001193125-21-326102
- form_type: 8-K
- ticker: IMA
- cik: 0001835579
- company_name: ImageneBio, Inc.
- filed_at: 2021-11-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835579/000119312521326102/0001193125-21-326102-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835579/000119312521326102/d254576d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-326102
- JSON: https://secwatch.observer/filing/0001193125-21-326102.json
- Plain text: https://secwatch.observer/filing/0001193125-21-326102.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.